| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 09/15/2005 | WO2005039484A3 Indolocarbazole anticancer agents and methods of using same |
| 09/15/2005 | WO2005000204A3 Pancreatic cancer treatment |
| 09/15/2005 | US20050203052 Antiinflammatory agents; antiarthritic agents; inflammatory resporatory disorders; antidiabetic agents |
| 09/15/2005 | DE4126475B4 13-Dihydro-3'-(2-Alkoxy-4-morpholinyl)anthracycline, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Zusammensetzungen 13-dihydro-3 '- (2-alkoxy-4-morpholinyl) anthracyclines, processes for their preparation, their use and compositions containing them |
| 09/15/2005 | DE102005007110A1 Metallisches Salz von N4-Acylcytidin-Derivaten und Verfahren zur Herstellung von N4-Acylcytidin-Derivaten unter dessen Verwendung Metallic salt of N4-Acylcytidin derivatives and process for producing N4-Acylcytidin derivatives under its use |
| 09/15/2005 | DE102004009704A1 New conjugates useful for labeling nucleic acids comprise a label coupled to nucleotide or nucleoside molecules through polymer linkers |
| 09/15/2005 | CA2557818A1 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry |
| 09/15/2005 | CA2557285A1 Adenosine receptor agonists |
| 09/15/2005 | CA2556829A1 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production |
| 09/14/2005 | EP1573038A2 A high resolution typing system for pathogenic mycobacterium tuberculosum |
| 09/14/2005 | EP1573035A2 Brother of the regulator of imprinted sites (boris) |
| 09/14/2005 | EP1572978A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 09/14/2005 | EP1572945A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 09/14/2005 | EP1572711A1 Anhydrous crystalline azido cytosine hemisulfate derivative |
| 09/14/2005 | EP1572710A2 Antiviral nucleoside derivatives |
| 09/14/2005 | EP1572709A2 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases |
| 09/14/2005 | EP1572708A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 09/14/2005 | EP1572705A2 Sugar modified nucleosides as viral replication inhibitors |
| 09/14/2005 | EP1572097A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 09/14/2005 | EP1572067A2 Conjugates and compositions for cellular delivery |
| 09/14/2005 | CN1668313A Medicinal composition for drug-induced neuropathy |
| 09/14/2005 | CN1666992A Medical use of catalpol and its homologs |
| 09/13/2005 | US6943249 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome |
| 09/09/2005 | WO2005082920A1 Crystalline forms of a pharmaceutical compound |
| 09/09/2005 | WO2005009287A3 Drug delivery to the inner ear and methods of using same |
| 09/09/2005 | CA2762878A1 Crystalline forms of a pharmaceutical compound |
| 09/08/2005 | US20050197316 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 09/07/2005 | EP1570090A2 A biological sample storage device and method for biological sample contamination testing |
| 09/07/2005 | EP1570043A2 Device and method for in-line blood testing using biochips |
| 09/07/2005 | EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 09/07/2005 | EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections |
| 09/07/2005 | EP1023308B1 Inhibitors of nucleoside metabolism |
| 09/07/2005 | CN1217952C Compound |
| 09/01/2005 | WO2005080404A1 Silyl linker for solid-phase synthesis of nucleic acid |
| 09/01/2005 | WO2005080351A1 The preparation and application of a n4-oxycarbonylcytosine derivatives |
| 09/01/2005 | WO2005079155A2 Photoreactive compound specifically binding to calcium binding proteins |
| 09/01/2005 | WO2005003374A3 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES |
| 09/01/2005 | US20050192433 Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same |
| 09/01/2005 | US20050192246 Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| 09/01/2005 | US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections |
| 09/01/2005 | US20050191711 Cerebral amyloid plaque precursors for use as diagnostic tool in detection of nervous system disorders |
| 09/01/2005 | US20050191689 Novel nucleic acid base pair |
| 09/01/2005 | US20050191660 Labelled oligonucleotides synthesized on solid-supports |
| 09/01/2005 | US20050191646 Nucleic acid analysis techniques |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | CA2557595A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/01/2005 | CA2556593A1 Silyl linker for solid-phase synthesis of nucleic acid |
| 09/01/2005 | CA2556054A1 Photoreactive compound specifically binding to calcium binding proteins |
| 08/31/2005 | EP1568703A1 Method of fluorination |
| 08/31/2005 | EP1567169A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 08/31/2005 | EP1567045A2 Methods for diagnosing the presence or stage of cancer |
| 08/31/2005 | EP1442137A4 Universal nucleotides for nucleic acid analysis |
| 08/31/2005 | EP1370569B1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides |
| 08/31/2005 | EP1263773A4 Oligonucleotide analogues, methods of synthesis and methods of use |
| 08/31/2005 | EP1230925B1 Use of a trifluridine derivative alone or combined with a thymidine phosphorylase inhibitor for the treatment of hiv |
| 08/31/2005 | CN1662536A Alkynylpurine compounds and production methods thereof |
| 08/31/2005 | CN1660874A Inner salt type compound of thiophosphate group containing fluorin added and synthesis |
| 08/31/2005 | CN1660873A Compound thiophosphates containing selenium with fluorin being added to and synthesis |
| 08/31/2005 | CN1660819A Ramification of N-carbethoxy cytosine and preparation method and application |
| 08/31/2005 | CN1216893C Nucleosides with anti-hepatitis B virus activity |
| 08/30/2005 | US6936709 By precipitating protected 2'-deoxycytidine in the form of a hydrated crystal from an aqueous solution and recovering the protected 2'-deoxycytidine |
| 08/30/2005 | US6936702 Charge-switch nucleotides |
| 08/30/2005 | US6936596 Adenosine derivatives and use thereof |
| 08/25/2005 | WO2005077966A1 Substituted pixyl protecting groups for oligonucleotide synthesis |
| 08/25/2005 | US20050187384 Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides |
| 08/24/2005 | EP1565481A1 Antiviral nucleoside derivatives |
| 08/24/2005 | EP1565480A2 Detectable labeled nucleoside analogs and methods of use thereof |
| 08/24/2005 | EP1565479A2 2'-o-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
| 08/24/2005 | EP1276749B1 Photo-labile coumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof |
| 08/24/2005 | CN1659179A System for tracing animal products |
| 08/23/2005 | US6933315 bis indole derivatives containing acetylated saccharide groups |
| 08/23/2005 | US6933288 Pyranosyl cytosines: pharmaceutical formulations and methods |
| 08/23/2005 | US6933260 Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4′-position |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | CA2111571C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/18/2005 | WO2005026318A3 Methods and compositions for producing antigenic responses |
| 08/18/2005 | WO2005003291A3 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 08/18/2005 | US20050182252 Novel 2'-C-methyl nucleoside derivatives |
| 08/18/2005 | US20050182019 Phosphonate compounds |
| 08/18/2005 | US20050182018 Method to reduce inflammatory response in transplanted tissue |
| 08/18/2005 | US20050182001 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus |
| 08/17/2005 | EP1563089A2 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 08/16/2005 | US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 08/16/2005 | US6930096 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free cdp-choline |
| 08/11/2005 | WO2005058247A3 Method for preparing radiolabeled thymidine having low chromophoric byproducts |
| 08/11/2005 | US20050176968 Process for producing indolopyrrolocarbazole derivative |
| 08/11/2005 | US20050176949 E.g., (2S, 3S, 4R, 5R)-2-(5-tert-butyl-[1,3,4]oxadiazol-2-yl)-5-[6-(4-chloro-2-fluoro-phenylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol, by aminating a 6-halopurine ribofuranose nucleoside in the presence of CaCO3 and an acid; adenosine A1 receptor agonist products are also claimed |
| 08/11/2005 | US20050176941 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof |
| 08/11/2005 | US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections |
| 08/11/2005 | US20050176656 4"-Deoxy-4"-(s)-amido avermectin derivatives |
| 08/11/2005 | US20050176038 Transcribed non-naturally occurring RNA sequences which form hairpin structures for use in treatment of cell proliferative disorders; gene therapy; antisense agents |
| 08/10/2005 | EP1561741A1 Method for deuteration or tritiation of heterocyclic ring |
| 08/10/2005 | EP1560838A1 Labelled nucleotides |
| 08/10/2005 | EP1355915B1 Labelling compounds for the simple synthesis of 3'(18f)fluoro-3'-deoxy thymidine and a method for the production thereof |
| 08/10/2005 | CN1653079A Intercalator containing pseudonucleotide(s) |
| 08/10/2005 | CN1653078A Method for synthesizing beta-L-fluoro-2', 3'-dideoxy-didehydrocytidine (beta-L-FD4C) |
| 08/10/2005 | CN1653077A Nucleoside derivatives for treating hepatitis C virus infection |
| 08/09/2005 | US6927291 Method for the synthesis of 2′,3′-dideoxy-2′,3′-didehydronucleosides |
| 08/09/2005 | CA2095659C Heteroatoms-containing tricyclic compounds |
| 08/04/2005 | WO2005070947A1 Synthesis of spongosine |